Division of Hologic Inc.
Latest From Gen-Probe Inc.
Hologic's partner in the blood-screening business, Grifols SA, will buy-out Hologic's share for $1.85bn. Grifols already owns all the customer-facing parts of the business; it will now take on research, development and manufacture of assays and instruments based on nucleic acid testing for transfusion and transplantation screening.
Recent regulatory events and dealmaking highlight an increase in the pace of innovation in rapid infectious disease testing.
Enzo and Illumina settle patent battle; Bard and Gore argue over jury logistics for an upcoming trial; and former employee alleges False Claims Act violations by medical equipment maker Lincare.
A new refuse-to-accept guidance; FDA finalizes classification decisions; and the agency awards an emergency authorization for a new rapid Ebola assay.
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
- Research, Analytical Equipment & Supplies
- Therapeutic Areas
- Infectious & Viral Diseases
- North America
- Parent & Subsidiaries
- Hologic Inc.
- Senior Management
Carl W Hull, Pres. & CEO
Tadd Lazarus, MD, VP & Chief Medical Officer
Eric E Tardif, PhD, SVP, Corp. Dev. & Mktg.
- Contact Info
Phone: (858) 410-8000
10210 Genetic Center Dr.
San Diego, CA 92121
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.